Zobrazeno 1 - 10
of 274
pro vyhledávání: '"O. Beyne-rauzy"'
Autor:
G. Grouteau, F. Lafourcade, H. Fayolle, E. Maupoint, C. Ricard, G. Pugnet, G. Moulis, S. De Almeida Chaves, J. Maquet, A. Toledano, L. Balardy, A. Bura-Rivière, A. Constantin, O. Beyne-rauzy, P. Delobel, L. Alric, A. Hitzel, M. Faruch-Bilfeld, L. Sailler
Publikováno v:
La Revue de Médecine Interne. 43:A394-A395
Autor:
T, Comont, J, Belliere, V, Sibaud, L, Alric, N, Meyer, J, Mazières, P, Caron, B, Acket, J-M, Michot, O, Beyne-Rauzy, O, Lambotte
Publikováno v:
La Revue de Médecine Interne
La Revue de Médecine Interne, 2020, 41 (1), pp.37-45. ⟨10.1016/j.revmed.2019.09.005⟩
La Revue de Médecine Interne, 2020, 41 (1), pp.37-45. ⟨10.1016/j.revmed.2019.09.005⟩
International audience; Use of checkpoint inhibitors to treat cancer was one of the most important revolution these last years and an increasing number of new types of tumors is currently under investigation with these new treatments. However, immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9355f90b4e8806b810055a928efc4ff2
https://hal.science/hal-03489720
https://hal.science/hal-03489720
Autor:
S. Tavitian, Stanislas Faguer, Dominique Chauveau, Véronique Demas, David Ribes, C. Koundé, M. Colombat, O. Beyne Rauzy, Christian Recher, Julie Belliere
Publikováno v:
Néphrologie & Thérapeutique. 16:319-320
Introduction L’avenement des therapies ciblees et l’identification de signatures moleculaires specifiques ont revolutionne le champ de l’« onco-nephrologie », necessitant une approche multidimensionnelle des hemopathies associant hematologues
Publikováno v:
La Revue de medecine interne. 40(9)
Myelodysplastic syndromes are a heterogeneous group of clonal myeloid disorders characterized by peripheral cytopenias and an increased risk of progression to acute myeloid leukemia. Inflammatory, auto-immune or syndromic symptoms can make the diagno
Autor:
C. Ricard, Pierre Payoux, F. Lafourcade, Laurent Balardy, O. Beyne Rauzy, Laurent Sailler, A. Constantin, Anne Hitzel, G. Grouteau, H. Fayolle, M. Faruch, P. Delobel, Laurent Alric
Publikováno v:
Annals of the Rheumatic Diseases. 79:1836.1-1837
Background:Making the diagnosis of aortitis may be challenging in the “real life”.18F-FDG PET/CT (PET) has emerged has the gold standard to diagnose aortitis but it is expensive and not always quickly available. Injected CT-scan (CT) can also be
Autor:
M.‐L. Piel‐Julian, M. Mahévas, J. Germain, L. Languille, T. Comont, M. Lapeyre‐Mestre, B. Payrastre, O. Beyne‐Rauzy, M. Michel, B. Godeau, D. Adoue, G. Moulis, L. Alric, S. Arista, L. Astudillo, L. Balardy, S. Betrian, D. Bonnet, C. Borel, D. Brechemier, N. Brun, M. Carreiro, B. Castel, L. Caudrelier, P. Cougoul, A. Danu, K. Delavigne, C. Dingremont, T. Faurie, F. Gaches, M.‐H. Gaspard, C. Gaudin, A. Godel‐Labouret, P. Giraud, S. Hadj‐Khelifa, B. Hebraud, S. Khatibi, L. Leplay, Y. Leveneur, N. Limal, S. Ollier, S. Madaule, B. Marchou, C. Martel, G. Martin‐Blondel, P. Montane De La Roque, M. Michaud, J. Moeglin, F. Nuccio, L. Prudhomme, G. Pugnet, C. Recher, V. Remy, L. Sailler, S. Sire, A. Sommet, S. Tavitian, M.‐F. Thiercelin‐Legrand, W. Vaillant
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2018, 16 (9), pp.1830-1842. ⟨10.1111/jth.14227⟩
Journal of Thrombosis and Haemostasis, 2018, 16 (9), pp.1830-1842. ⟨10.1111/jth.14227⟩
Journal of Thrombosis and Haemostasis, Wiley, 2018, 16 (9), pp.1830-1842. ⟨10.1111/jth.14227⟩
Journal of Thrombosis and Haemostasis, 2018, 16 (9), pp.1830-1842. ⟨10.1111/jth.14227⟩
International audience; Essentials Risk factors of bleeding in adult immune thrombocytopenia are not known. This multicenter study assessed risk factors of bleeding at immune thrombocytopenia onset. Platelet count thresholds associated with bleeding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0050afed18365717399227082054ee58
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03141842
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03141842
Autor:
Raphael Itzykson, Aline Renneville, Francois Dreyfus, Thorsten Braun, Thomas Cluzeau, Shanti Natarajan-Amé, Agnès Guerci-Bresler, Dominique Bordessoule, Norbert Vey, Christian Rose, Sophie Raynaud, Thomas Prebet, Jacques Delaunay, Sophie Park, Bruno Quesnel, Andrea Toma, Marie Robin, O Beyne Rauzy, Fatiha Chermat, Aspasia Stamatoullas, Olivier Kosmider, Françoise Isnard, Lionel Adès, Virginie Eclache, Stéphane Cheze, Eric Solary, Claude Gardin, Emmanuel Gyan, Claude Preudhomme, Eric Wattel, Sylvain Thepot, Groupe de travail : P Fenaux, S Dimicoli, I Yakoub Agha, Michaela Fontenay
Publikováno v:
Hématologie. 21:28-45
Les syndromes myelodysplasiques (SMD) sont des affections clonales des cellules souches pluripotentes, caracterisees par une hematopoiese inefficace, responsable de cytopenies sanguines qui contrastent avec une moelle generalement riche. De plus, les
Autor:
Working Group: P Fenaux, L Ades, M Fontenay, S Raynaud, V Eclache, C Rose, A Guerci-Bresler, E Gyan, M Robin, T Prebet, R Itzykson, T Cluzeau, S Natarajan-Amé, A Stamatoullas, E Wattel, S Park, O Beyne Rauzy, E Solary, D Bordessoule, F Isnard, B Quesnel, I Yakoub Agha, A Toma, S Thépot, T Braun, C Gardin, S Chèze, J Delaunay, S Dimicoli, O Kosmider, A Renneville, C Preudhomme, F Chermat, N Vey, F Dreyfus
Publikováno v:
Hématologie. 21:46-59
MDS are clonal pluripotent, stem cell disorders characterized by ineffective hematopoiesis resulting in blood cytopenias contrasting with a typically cellular marrow. MDS evolve frequently to acute myeloid leukemia (AML), and are the most frequent pr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E. Chalayer, J Tebib, J Ninet, P Cathébras, Olivier Lambotte, B Asli, O Beyne-Rauzy, S Durupt, N Costedoat-Chalumeau, M. Ffrench, C. Vasselon
Publikováno v:
QJM: An International Journal of Medicine.
Background Besides peripheral cytopenias, bone marrow abnormalities, such as fibrosis, pure red cell aplasia and aplastic anemia have been reported in patients with systemic lupus erythematosus (SLE), suggesting that bone marrow may be a 25 target or